With the recent explosion of healthcare data in the U.S. as well as the announcement of several well-publicized partnerships between manufacturers and providers or payers, the emergence of data collaborations is currently one of the hottest trends in healthcare.

It’s no secret that the pharmaceutical industry is facing a series of unprecedented challenges.  Payers are increasingly demanding that new products and treatments demonstrate both economic and clinical value, as escalating healthcare costs are no longer considered sustainable. With mounting pressure from payers as well as increased regulatory scrutiny and financial penalties tied to clinical performance, providers are also becoming much more focused on cost and outcomes – a trend that’s expected to accelerate as provider consolidation continues.

Read More

Thank you for your interest in our content. Registering allows you to access a wide range of informative articles, briefs, and whitepapers throughout the site.

Privacy is important. We do not share registrant information with anyone outside of Numerof & Associates. For details, please see our Privacy Policy. Subscribers to our mailings can unsubscribe instantly at any time.